These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 6112039

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pirbuterol: a new oral sympathomimetic amine for the treatment of congestive heart failure.
    Sharma B, Hoback J, Francis GS, Hodges M, Asinger RW, Cohn JN, Taylor CR.
    Am Heart J; 1981 Sep; 102(3 Pt 2):533-41. PubMed ID: 6115572
    [Abstract] [Full Text] [Related]

  • 4. Pirbuterol hydrochloride: evaluation of beta adrenergic agonist activity in reversible obstructive pulmonary disease and congestive heart failure.
    Weber RW, Nelson HS.
    Pharmacotherapy; 1984 Sep; 4(1):1-10. PubMed ID: 6142449
    [Abstract] [Full Text] [Related]

  • 5. Symptoms, haemodynamics, and exercise capacity during long term treatment of chronic heart failure. Experience with pirbuterol.
    Dawson JR, Canepa-Anson R, Kuan P, Reuben SR, Poole-Wilson PA, Sutton GC.
    Br Heart J; 1983 Sep; 50(3):282-9. PubMed ID: 6137226
    [Abstract] [Full Text] [Related]

  • 6. Effects of pirbuterol and sodium nitroprusside on pulmonary haemodynamics in hypoxic cor pulmonale.
    MacNee W, Wathen CG, Hannan WJ, Flenley DC, Muir AL.
    Br Med J (Clin Res Ed); 1983 Oct 22; 287(6400):1169-72. PubMed ID: 6138118
    [Abstract] [Full Text] [Related]

  • 7. Single-dose and dose-response studies with oral pirbuterol, a new beta agonist in chronic heart failure.
    Canepa-Anson R, Dawson JR, Kuan P, Warnes CA, Poole-Wilson PA, Reuben SR, Sutton GC.
    Am Heart J; 1981 Sep 22; 102(3 Pt 2):578-83. PubMed ID: 6115575
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Acute effects of oral pirbuterol on myocardial oxygen metabolism and systemic hemodynamics in chronic congestive heart failure.
    Rude RE, Turi Z, Brown EJ, Lorell BH, Colucci WS, Mudge GH, Taylor CR, Grossman W.
    Circulation; 1981 Jul 22; 64(1):139-45. PubMed ID: 7237712
    [Abstract] [Full Text] [Related]

  • 10. Hemodynamic effects of oral pirbuterol in chronic severe congestive heart failure.
    Awan NA, Evenson MK, Needham KE, Evans TO, Hermanovich J, Taylor CR, Amsterdam E, Mason DT.
    Circulation; 1981 Jan 22; 63(1):96-101. PubMed ID: 7438412
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of the beta-adrenergic receptor agonist pirbuterol on cardiac performance during acute ischaemic left ventricular failure in dogs.
    Smiseth OA.
    Eur J Pharmacol; 1983 Mar 04; 87(4):379-86. PubMed ID: 6133759
    [Abstract] [Full Text] [Related]

  • 13. Potential value of oral beta 2-adrenoceptor agonists in congestive heart failure: a haemodynamic and metabolic study.
    Timmis AD, Bergman G, Walker L, Monaghan MJ, Jewitt DE.
    Int J Cardiol; 1984 Mar 04; 5(3):327-38. PubMed ID: 6706438
    [Abstract] [Full Text] [Related]

  • 14. Differences between acute and long-term metabolic and endocrine effects of oral beta-adrenoceptor agonist therapy with pirbuterol for cardiac failure.
    Canepa-Anson R, Dawson JR, Kuan P, Poole-Wilson PA, Sutton GC, Cockrill B, Reuben SR.
    Br J Clin Pharmacol; 1987 Feb 04; 23(2):173-81. PubMed ID: 3828194
    [Abstract] [Full Text] [Related]

  • 15. Acute and chronic effects of pirbuterol on left ventricular ejection fraction and clinical status in severe congestive heart failure.
    Colucci WS, Alexander RW, Mudge GH, Rude RE, Holman BL, Wynne J, Grossman W, Braunwald E.
    Am Heart J; 1981 Sep 04; 102(3 Pt 2):564-8. PubMed ID: 6115573
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Response of pulmonary circulation to oral pirbuterol in chronic airflow obstruction.
    Peacock A, Busst C, Dawkins K, Denison DM.
    Br Med J (Clin Res Ed); 1983 Oct 22; 287(6400):1178-80. PubMed ID: 6138119
    [Abstract] [Full Text] [Related]

  • 19. Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol.
    Colucci WS, Alexander RW, Williams GH, Rude RE, Holman BL, Konstam MA, Wynne J, Mudge GH, Braunwald E.
    N Engl J Med; 1981 Jul 23; 305(4):185-90. PubMed ID: 6113543
    [Abstract] [Full Text] [Related]

  • 20. Intravenous pirbuterol.
    Leier CV, Nelson S, Huss P, Bianchine JR, Olukotun AY, Taylor CR, Salzburg DS.
    Clin Pharmacol Ther; 1982 Jan 23; 31(1):89-94. PubMed ID: 7053311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.